Holen Sie sich die Stockscreener-App
96.43
3.84%
3.57
Handel nachbörslich:
96.36
-0.07
-0.07%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck Writes a $9.2 Billion Check for a Flu Drug That Could Change Everything - Finviz
WBI Investments LLC Buys 8,548 Shares of Merck & Co., Inc. $MRK - MarketBeat
Deutsche Bank Aktiengesellschaft Raises Merck & Co., Inc. (NYSE:MRK) Price Target to $111.00 - MarketBeat
Merck & Co, Amer Sports among market cap stock movers on Tuesday - Investing.com
Merck & Co., Inc. (NYSE:MRK) Shares Up 3.6%Still a Buy? - MarketBeat
Merck’s Winrevair Success Expands Beyond Pulmonary HypertensionMerck & Co (NYSE:MRK) - Benzinga
Merck Announces First-Quarter 2026 Dividend - Business Wire
Merck, Bristol announce additional layoffs in New Jersey - Seeking Alpha
Merck posts trial win for Winrevair in new indication (MRK) - Seeking Alpha
Merck & Co., Inc. $MRK Shares Acquired by Invenio Wealth Partners LLC - MarketBeat
Merck (NYSE: MRK) Reports WINREVAIR PVR Reduction in Phase 2 CADENCE HFpEF Study - Stock Titan
Frank Rimerman Advisors LLC Grows Stake in Merck & Co., Inc. $MRK - MarketBeat
Cordatus Wealth Management LLC Sells 9,760 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stake Lessened by Empowered Funds LLC - MarketBeat
Merck Has Many Bullish Attributes (Technical Analysis) - Seeking Alpha
Merck Buys Cidara In $9.2 Billion Deal—Here’s What They’re Really After! - Smartkarma
Cell Harvesting Market to Reach USD 20.08 Billion, Growing at a Strong 12.95% CAGR by 2034 - GlobeNewswire Inc.
Merck sees over $5 billion opportunity in Cidara's experimental flu drug - Reuters
Westwood Holdings Group Inc. Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
Transcript : Cidara Therapeutics, Inc., Merck & Co., Inc.M&A Call - MarketScreener
LSV Asset Management Has $422.43 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Intrust Bank NA Decreases Stake in Merck & Co., Inc. $MRK - MarketBeat
Nomura Asset Management Co. Ltd. Has $122.30 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Rothschild Investment LLC Cuts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Symphony Financial Ltd. Co. Acquires New Position in Merck & Co., Inc. $MRK - MarketBeat
Raiffeisen Bank International AG Has $57.28 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Jefferies Adjusts Price Target on Merck & Co. to $138 From $137, Maintains Buy Rating - MarketScreener
Chiron Capital Management LLC Increases Position in Merck & Co., Inc. $MRK - MarketBeat
Bulltick Wealth Management LLC Acquires Shares of 18,717 Merck & Co., Inc. $MRK - MarketBeat
Avantax Advisory Services Inc. Buys 34,861 Shares of Merck & Co., Inc. $MRK - MarketBeat
Westpac Banking Corp Acquires 3,253 Shares of Merck & Co., Inc. $MRK - MarketBeat
Thoroughbred Financial Services LLC Has $1.31 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
WealthShield Partners LLC Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Persistent Asset Partners Ltd Makes New $368,000 Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Generali Investments Management Co LLC - MarketBeat
Thomas Story & Son LLC Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Rockefeller Capital Management L.P. Buys 35,011 Shares of Merck & Co., Inc. $MRK - MarketBeat
Letko Brosseau & Associates Inc. Buys 106,380 Shares of Merck & Co., Inc. $MRK - MarketBeat
Kingsview Wealth Management LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Massachusetts Financial Services Co. MA Sells 303,327 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Cornerstone Advisors LLC - MarketBeat
Cetera Investment Advisers Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Citizens Financial Group Inc. RI Sells 39,355 Shares of Merck & Co., Inc. $MRK - MarketBeat
Empower Advisory Group LLC Has $13.21 Million Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Campbell & CO Investment Adviser LLC Sells 11,592 Shares of Merck & Co., Inc. $MRK - MarketBeat
Intech Investment Management LLC Trims Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Sculati Wealth Management LLC Reduces Holdings in Merck & Co., Inc. $MRK - MarketBeat
OmniStar Financial Group Inc. Has $1.10 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
78,389 Shares in Merck & Co., Inc. $MRK Bought by Beacon Harbor Wealth Advisors Inc. - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Merck Wilmington Biotech Facility, Delaware, USA - Pharmaceutical Technology
Merck & Co., Inc. $MRK Stock Position Raised by Advisors Capital Management LLC - MarketBeat
Merck Offers $9.2bn To Buy Cidara And Phase III Antiviral Flu Preventative - Citeline News & Insights
Merck buys Cidara for $9.2B as Keytruda patent loss looms - BioWorld MedTech
Merck Buys Cidara For $9.2 Billion To Add Flu Drug - Finimize
Merck's Cidara Buyout Is An Opportunistic Win For Both PartiesHere's Why (NASDAQ:CDTX) - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Upgraded at Scotiabank - MarketBeat
Merck agrees $9.2bn deal for flu-prevention biotech Cidara - Financial Times
Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal - Bloomberg.com
What's Going On With Merck Stock Friday?Merck & Co (NYSE:MRK), Cidara Therapeutics (NASDAQ:CDTX) - Benzinga
Merck to acquire Cidara Therapeutics for $9.2B - Proactive financial news
Do You Believe in Merck & Co.’s (MRK) Upside Potential? - Insider Monkey
Olympiad Research LP Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. agreed to acquire Cidara Therapeutics, Inc.. - MarketScreener
Grandfield & Dodd LLC Has $15.28 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Oak Harvest Investment Services Purchases 4,194 Shares of Merck & Co., Inc. $MRK - MarketBeat
Phoenix Wealth Advisors Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
Good Life Advisors LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Impax Asset Management Group plc Sells 252,213 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck to acquire Cidara for $221.50/share in $9.2 billion deal; CDTX soars (MRK:NYSE) - Seeking Alpha
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent - Business Wire
MerckBacillus of Calmette and Guerin (BCG) Vaccine for Percutaneous UseBrochure - Environmental XPRT
Donoghue Forlines LLC Acquires 2,755 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Burling Wealth Partners LLC - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Has $37.66 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Belén Garijo’s prescription for Germany’s Merck - https-//www.semafor.com
Merck & Co., Inc. $MRK Stake Decreased by Arvest Bank Trust Division - MarketBeat
1.48%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):